Device Therapy: the future is now.



Similar documents
Updated Cardiac Resynchronization Therapy Guidelines

Clinical Commissioning Policy Statement: Percutaneous mitral valve leaflet repair for mitral regurgitation April Reference: NHSCB/A09/PS/b

Managing Mitral Regurgitation: Repair, Replace, or Clip? Michael Howe, MD Traverse Heart & Vascular

Listen to your heart: Good Cardiovascular Health for Life

How should we treat atrial fibrillation in heart failure

Heart Failure: From Prevention to Intervention

Steven J. Yakubov, MD FACC For the CoreValve US Clinical Investigators

Stanford s Cardiovascular Surgery and Medicine Symposium

Functional Improvement for Heart Failure Patients After Left Ventricular Assistive Device Placement in a Free Standing Rehabilitation Hospital

Cardiovascular Disease and Maternal Mortality what do we know and what are the key questions?

CARDIAC RISKS OF NON CARDIAC SURGERY

24 th Annual Conference on Cardiovascular Nursing

Mille in Italia e oltre: ABC per il clinico sulle indicazioni e sull implementazione in rete del Sistema MitraClip

Advance Directives and Durable Power of Attorney for Health Care

LEADING-EDGE Cardiovascular Care

Mitral Valve Repair versus Replacement for Severe Ischemic Mitral Regurgitation. Michael Acker, MD For the CTSN Investigators AHA November 2013

Management of Symptomatic Atrial Fibrillation


Atrial Fibrillation 2014 How to Treat How to Anticoagulate. Allan Anderson, MD, FACC, FAHA Division of Cardiology

California Advance Health Care Directive

November 15, Ann Laramee MS ANP-BC ACNS-BC CHFN FletcherAllen.org

Contemporary Management of Cardiovascular Disease

Electrocardiographic Issues in Williams Syndrome

To Bridge or Not to Bridge. Periop Anticoagulation Management. Don Weinshenker, MD Ambulatory Care Denver VAMC

Utilization Review Cardiac Rehabilitation Services: Underutilized

Echocardiography Guided Cardiac Resynchronization Therapy in Patients with Symptomatic Heart Failure and Narrow QRS Complex

Power of Attorney for Health Care For

Ottavio Alfieri S. Raffaele University Hospital, Milano

Christopher M. Wright, MD, MBA Pioneer Cardiovascular Consultants Tempe, Arizona

Cancer Treatment and the Heart Cardio-Oncology September 12, 2014

Mechanical Circulatory Support and End of Life Care. 10 th Annual Interdisciplinary Transplant Symposium 24 September 2015

Type II Pulmonary Hypertension: Pulmonary Hypertension due to Left Heart Disease

FY2015 Proposed Hospital Inpatient Rule Summary

2/20/2015. KPNW Region. NW Service Delivery History

Heart Failure Review Course

My Voice. Advance Care Plan

What Are Arrhythmias?

The Ohio State University s Second Annual Valve and Structural Heart Disease Conference: Transcatheter Management of Aortic Valve Disease

STEMI & CARDIAC ARREST

Cardiopulmonary Exercise Stress Test (CPET) Archived Medical Policy

Geographic Differences in Healthcare Utilization: Moving Forward. Allen J. Taylor MD FACC FAHA

How To Improve Health Care For Remote Workers

How to control atrial fibrillation in 2013 The ideal patient for a rate control strategy

New Anticoagulants and GI bleeding

FAQ. The Kidney Project

Medical management of CHF: A New Class of Medication. Al Timothy, M.D. Cardiovascular Institute of the South

DEVICE RECALLS: The Era of Regulation and Outcome Metrics: Optimizing Benefits and Managing Risks

San Antonio Heart Failure Symposium 2015

on behalf of the AUGMENT-HF Investigators

The State of the Liver in the Adult Patient after Fontan Palliation

Cardiac Rehabilitation The Best Medicine for Your CAD Patients. James A. Stone

AN ADVANCE CARE DIRECTIVE A GIFT OF PREPAREDNESS

2012 Innovations in Heart Failure and Pulmonary Hypertension

Presenter Disclosure Information

Renovascular Hypertension

FY2015 Final Hospital Inpatient Rule Summary

The Emerging Atrial Fibrillation Epidemic: Treat It, Leave It or Burn It?

Real-Time 3-Dimensional Transesophageal Echocardiography in the Evaluation of Post-Operative Mitral Annuloplasty Ring and Prosthetic Valve Dehiscence

Medical Coding COURSE BROCHURE & SYLLABUS

Diseases and Health Conditions that can Lead to Daytime Sleepiness

ΠΟΙΟ ΑΝΤΙΠΗΚΤΙΚΟ ΓΙΑ ΤΟΝ ΑΣΘΕΝΗ ΜΟΥ? ΚΛΙΝΙΚΑ ΠΑΡΑΔΕΙΓΜΑΤΑ. Σωκράτης Παστρωμάς Καρδιολόγος Νοσοκομείο Ερρίκος Ντυνάν

7th annual ConFerenCe location

James F. Kravec, M.D., F.A.C.P

Antiplatelet and Antithrombotics From clinical trials to guidelines

The National Service Framework for Cardiac Disease: Strategic Aims and Implementation A Cardiac Work Programme for Wales

STANDARDS FOR IMPLANTATION AND FOLLOW-UP OF CARDIAC RHYTHM MANAGEMENT DEVICES IN ADULTS January 2013

2014 Emerging Faculty Participants

Status Active. Assistant Surgeons. This policy addresses reimbursement for assistant surgical procedures during the same operative session.

RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY. Charles Jazra

The Anticoagulated Patient A Hematologist s Perspective

Active Rehabilitation and Physical Therapy During Extracorporeal Membrane Oxygenation While Awaiting Lung Transplantation

Valve Disease and Diastology Summit

Abe DeAnda Jr., MD. Associate Professor, Department of Cardiothoracic Surgery NYU Langone Medical Center

New Oral AntiCoagulants (NOAC) in 2015

Cardiac Assessment for Renal Transplantation: Pre-Operative Clearance is Only the Tip of the Iceberg

DH Cardiac Rehabilitation Commissioning Pack: highlights and process. Prof Patrick Doherty BACR conference Liverpool 2010

Centers for Medicare & Medicaid Services 7500 Security Boulevard Baltimore, MD 21244

Managing the Patient with Atrial Fibrillation

Mitral valve repair current Status and the modern Sternotomy

Implementing a Prehospital 12-Lead Program

Implantable Cardioverter Defibrillator Treatment: Benefits and Pitfalls in the Currently Indicated Population. Carel Jan Willem Borleffs

Cardio-Pulmonary Resuscitation (CPR): A Decision Aid For. KGH Patients And Their Families

Diagnostic and Therapeutic Procedures

Heart Failure Best Practice Strategies: Featuring Target: HF Honor Roll Hospitals

Telecardiology Technical Innovations and Challegenes in Clinical Practice

Berlin Heart EXCOR Ventricular Assist Device

Transcription:

Device Therapy: the future is now. Mariell Jessup MD FAHA, FACC, FESC Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania, USA

Disclosure: Mariell Jessup MD University of Pennsylvania Speakers Bureau: Advisory Board: Honorarium: NONE

Device dɪˈvʌɪs noun a thing made or adapted for a particular purpose, especially a piece of mechanical or electronic equipment. synonyms: implement, gadget, utensil, tool, appliance, piece of equipment, apparatus, piece of apparatus, piece of hardware, instrument, machine, mechanism, contrivance, contraption, invention, convenience, amenity.

Heart Failure Device Therapy Implanted electrical devices: ICD, CRT Mechanical circulatory support devices Short term versus durable devices Valvular closure or replacement devices Monitoring devices Stimulation HF devices Personal wearable devices.

Heart Failure Device Therapy Implanted electrical devices: ICD, CRT Mechanical circulatory support devices Short term versus durable devices Valvular closure or replacement devices Monitoring devices Stimulation HF devices Personal wearable devices.

Secondary Prevention 2008 ACC/AHA/HRS Guidelines for Device-Based Therapy

Primary Prevention 2008 ACC/AHA/HRS Guidelines for Device-Based Therapy

Camm and Nisam Europace (2010) 12, 1063 1069

Masoudi et al. J Am Coll Cardiol 2013;62:1931 47

Camm and Nisam Europace (2010) 12, 1063 1069

17% reduction in mortality.

ACC/AHA guidelines, 2012

Heart Failure Device Therapy Implanted electrical devices: ICD, CRT Mechanical circulatory support devices Short term versus durable devices Valvular closure or replacement devices Monitoring devices Stimulation HF devices Personal wearable devices.

the OPTIONS

Sick patient Chronic support Temporary support Unclear situation Durable VADs pulsatile non-pulsatile 1. Support circulation 2. Oxygenate patient Choice dictated by clinical status: temporary support ECMO

~ ½ of the patients who need an MCSD for shock survive, and ~ ½ of these survivors require an implantable VAD. Ongoing CPR is predictive of in- hospital mortality.

VADs are getting better, but heart transplant is still the gold standard.

Heart Failure Device Therapy Implanted electrical devices: ICD, CRT Mechanical circulatory support devices Short term versus durable devices Valvular closure or replacement devices Monitoring devices Stimulation HF devices Personal wearable devices.

Mitral Clip

we conclude the non-inferiority of the MitraClip as a treatment for severe, symptomatic MR, in comparison to conventional valvular surgery. Despite a higher risk profile in the MitraClip patients, the clinical outcomes were comparable although surgery was more effective in reducing MR in the early post procedure period.

TAVR

Heart Failure Device Therapy Implanted electrical devices: ICD, CRT Mechanical circulatory support devices Short term versus durable devices Valvular closure or replacement devices Monitoring devices Stimulation HF devices Personal wearable devices.

Heart Failure Device Therapy Implanted electrical devices: ICD, CRT Mechanical circulatory support devices Short term versus durable devices Valvular closure or replacement devices Monitoring devices Stimulation HF devices Personal wearable devices.

Heart Failure Device Therapy Implanted electrical devices: ICD, CRT Mechanical circulatory support devices Short term versus durable devices Valvular closure or replacement devices Monitoring devices Stimulation HF devices Personal wearable devices.

Further understanding of information shared by the public in this forum could suggest new approaches for improving resuscitation related education.

Thank You